潤邁德(02297.HK)首席執行官及副總裁等職位變動
潤邁德醫療-B(02297.HK)公布,霍雲飛因內部管理調整辭任首席執行官,且不再為提名委員會主席;呂永輝因內部管理調整辭任執行董事;及谷陽因擬履行其他職務及需要投入更多時間照顧家庭而辭任執行董事兼副總裁,並不再擔任薪酬委員會成員。上述職位調整均自昨日(15日)起生效。
於辭任後,霍雲飛將仍為董事會主席、執行董事及根據上市規則第3.05條公司的授權代表,及呂永輝將仍為聯席首席執行官。
董事會進一步宣布,朱則柯已獲委任為執行董事兼聯席首席執行官,而段靜則獲委任為執行董事,自同日起生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.